E-health provider CompuGroup Medical has announced a strategic investment partnership with private equity firm CVC Capital Partners. CompuGroup specializes in medical software that enhances processes in various healthcare settings, including doctors' offices, pharmacies, and hospitals.

The partnership will take effect if a holding company controlled by CVC successfully completes a voluntary public tender offer for all outstanding shares of CompuGroup at €22.00 per share in cash. This offer represents a 51.1% premium over the average share price from the past three months and is contingent upon a minimum acceptance threshold of 17% and standard regulatory approvals, including antitrust clearance.

As part of the agreement, the founding Gotthardt family and shareholder Dr. Reinhard Koop, who collectively own 50.1% of the shares, will maintain a majority stake in CompuGroup Medical. Founder Frank Gotthardt will remain as chairman of the administrative board, while Daniel Gotthardt will continue as CEO and board member.

CVC Managing Partner Daniel Pindur expressed enthusiasm for the collaboration, highlighting CompuGroup as a leading example of a founder-led business in Germany. He noted the company's significant role in the digitization of healthcare and emphasized the intention to work closely with the Gotthardt family to advance the company’s growth.

Can Toygar, a senior managing director at CVC, pointed out the increasing demand for digital solutions in healthcare due to demographic shifts and labor shortages. He described CompuGroup as uniquely positioned to enhance healthcare efficiency in Europe. The focus will be on investing in modern, data-driven products and improving service quality for healthcare professionals.

The transaction is anticipated to close in the first half of 2025.